The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, October 02, 2019
AstraZeneca Pharmaceuticals
AstraZeneca announced the FDA has issued a CRL rejecting the NDA for PT010, an inhaled triple-combination therapy for COPD.
read more
Tuesday, October 01, 2019
BlueWillow Biologics® has been awarded a Fast-Track SBIR contract from the NIAID for the development of an intranasal therapeutic peanut allergy ...
read more
Monday, September 30, 2019
Eli Lilly presented data from the LIBRETTO-001 clinical trial intended to support the registration of oral selpercatinib1 monotherapy for the ...
read more
Friday, September 27, 2019
89bio has initiated dosing in its proof of concept Phase 1b/2a clinical trial evaluating its product candidate, BIO89-100, in patients with NASH or ...
read more
Thursday, September 26, 2019
Galmed Pharmaceuticals announced the initiation of its Phase 3/4 ARMOR clinical study to evaluate the efficacy and safety of Aramchol in subjects with...
read more
Wednesday, September 25, 2019
The FDA announced the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the prevention of smallpox and monkeypox disease ...
read more
Tuesday, September 24, 2019
Bayer, Brigham and Women's Hospital, and Massachusetts General Hospital announced the launch of a joint lab to research new drug candidates to treat ...
read more
Tuesday, September 24, 2019
Over the past few years we’ve witnessed new medical breakthroughs that are altering how diseases are treated in ways that seemed unimaginable just a ...
read more
Monday, September 23, 2019
Addressing opioid overdose continues to be one of the most urgent public health priorities for the U.S. government and making potentially lifesaving ...
read more
Monday, September 23, 2019
Amydis has received a Phase 2A SBIR grant award from the National Institute on Aging of the National Institutes of Health (NIH).
read more
Friday, September 20, 2019
The FDA approved Rybelsus (semaglutide) oral tablets to improve control of blood sugar in adult patients with type 2 diabetes, along with diet and ...
read more
Friday, September 20, 2019
Reneo announced the FDA Office of Orphan Products Development has granted Orphan Drug Designation to REN001 for the treatment of fatty acid oxidation ...
read more
Thursday, September 19, 2019
Trovagene announced the successful completion of its Phase 1b trial of onvansertib in combination with standard-of-care chemotherapy in AML and ...
read more
Wednesday, September 18, 2019
Pulmatrix announced the first patient has been dosed in the Phase 2 trial evaluating Pulmazole for Allergic Bronchopulmonary Aspergillosis (ABPA) in ...
read more
Monday, September 16, 2019
Seattle Genetics and Astellas announced the FDA has accepted the BLA for the investigational agent enfortumab vedotin for locally advanced or ...
read more